angiogenic siRNA therapy (alphaGEN)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameangiogenic siRNA therapy (alphaGEN)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiogenesis stimulantsBone modulators
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesalphaGEN Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesalphaGEN Co Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A